INNOVACAPInnova Captab Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹973.25
▲ 1.10%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)5,569.40
P/E39.48
P/B5.11
PEG1.38
ROE %13.75
ROCE %13.10
Debt / Equity0.32
EPS24.65
Revenue Growth %42.30
Profit Growth %28.60
Dividend Yield %0.21
Promoter Holding %72.19
FII Holding %18.83
DII Holding %—
Beta-0.05
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹973.25 | ₹935.30 | ₹1,054.00 | 2.13 |
BUYConviction 81%
Why buy
- • Revenue growth: 42.3% YoY
- • Profit growth: 28.6% YoY
- • Debt/Equity: 0.32
- • RSI: 54
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • Revenue growth: 42.3% YoY
- • Profit growth: 28.6% YoY
- • Debt/Equity: 0.32
- • RSI: 54
Bear case
- • Dividend yield: 0.21%
- • MACD: bearish
- • Volume: 0.7x 20-day average
- • Volume trend: 0.8x baseline
Key risks
- • Dividend yield: 0.21%
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹973.25
Stop Loss
₹908.82
risk 6.6%
Target 1 (1.5R)
₹1,069.89
+9.9%
Target 2 (3R)
₹1,166.54
+19.9%
Support (20d)
₹918.00
Resistance (52w)
₹1,034.85
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹64.43/share
ATR (volatility)
₹37.95
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹37.95). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
78
Technical
67
Momentum
78
Risk (safety)
56